Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Merck & Co. reports farnesyl transferase inhibitors

April 5, 1996

Antineoplastic fusion proteins from Bristol-Myers Squibb

April 5, 1996

MAbs for treatment of melanoma

April 5, 1996

BMS reports mutant BR96 antibodies

April 5, 1996

Yakult Honsha claims camptothecin derivatives

April 5, 1996

DuPont Merck research into protease inhibitors

April 5, 1996

New protease inhibitors from BMS

April 5, 1996

BMS discloses novel cephalosporins

April 5, 1996

Lilly's tachykinin antagonists for chronic pain

April 5, 1996

Tsumura Juntendo research into aldose reductase inhibitors

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...